Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Software errors lead to major insulin pump recall | FDA approves another GLP-1 pill | Premature menopause & the heart

News You Need to Know Today
Software errors lead to major insulin pump recall | FDA approves another GLP-1 pill | Premature menopause & the heart
Monday, April 6, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Health

Software errors lead to major insulin pump recall—manufacturer shares a fix

Nearly 27,000 MiniMed 780G insulin pumps were included in a new Class II recall. By taking a few basic steps, however, patients should be able to avoid any significant risks.

READ MORE >
Medtronic’s MiniMed 780G automated insulin delivery system
Share on Twitter Share on Facebook Share on Linkedin

Software errors lead to major insulin pump recall—manufacturer shares a fix

Share on Twitter Share on Facebook Share on Linkedin
Medtronic’s MiniMed 780G automated insulin delivery system
Nearly 27,000 MiniMed 780G insulin pumps were included in a new Class II recall. By taking a few basic steps, however, patients should be able to avoid any significant risks.
READ MORE >

FDA approves another GLP-1 pill for weight loss

The approval, made as part of a special FDA pilot program, took just 50 days.

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

FDA approves another GLP-1 pill for weight loss

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
The approval, made as part of a special FDA pilot program, took just 50 days.
READ MORE >

Whoop raises $575M—Abbott, LeBron James, Cristiano Ronaldo among the investors

Whoop, a Boston-based wearable technologies company, raised the new funding on a $10.1 billion evaluation.

READ MORE >
Whoop, a Boston-based wearable technologies company, has raised $575 million in new financing at a $10.1 billion valuation. Investors include Abbott, Mayo Clinic, LeBron James and Cristiano Ronaldo.
Share on Twitter Share on Facebook Share on Linkedin

Whoop raises $575M—Abbott, LeBron James, Cristiano Ronaldo among the investors

Share on Twitter Share on Facebook Share on Linkedin
Whoop, a Boston-based wearable technologies company, has raised $575 million in new financing at a $10.1 billion valuation. Investors include Abbott, Mayo Clinic, LeBron James and Cristiano Ronaldo.
Whoop, a Boston-based wearable technologies company, raised the new funding on a $10.1 billion evaluation.
READ MORE >

Premature menopause linked to substantial long-term heart risks

Starting menopause before the age of 40 could increase a woman's lifetime risk of coronary heart disease by up to 40%.

READ MORE >
female patient speaking with a doctor
Share on Twitter Share on Facebook Share on Linkedin

Premature menopause linked to substantial long-term heart risks

Share on Twitter Share on Facebook Share on Linkedin
female patient speaking with a doctor
Starting menopause before the age of 40 could increase a woman's lifetime risk of coronary heart disease by up to 40%.
READ MORE >

FDA clears MiniMed’s screenless, smartphone-controlled insulin pump

Just weeks after separating from Medtronic and going public, MiniMed secured FDA clearance for its next-generation insulin pump technology. 

READ MORE >
MiniMed Flex Medtronic
Share on Twitter Share on Facebook Share on Linkedin

FDA clears MiniMed’s screenless, smartphone-controlled insulin pump

Share on Twitter Share on Facebook Share on Linkedin
MiniMed Flex Medtronic
Just weeks after separating from Medtronic and going public, MiniMed secured FDA clearance for its next-generation insulin pump technology. 
READ MORE >

New dyslipidemia guideline puts add-on testing, early screening in the spotlight

The updated recommendations represent a collaboration between the American College of Cardiology, American Heart Association and several other U.S. healthcare organizations. 

READ MORE >
cardiologists heart doctors
Share on Twitter Share on Facebook Share on Linkedin

New dyslipidemia guideline puts add-on testing, early screening in the spotlight

Share on Twitter Share on Facebook Share on Linkedin
cardiologists heart doctors
The updated recommendations represent a collaboration between the American College of Cardiology, American Heart Association and several other U.S. healthcare organizations. 
READ MORE >

Another win for Wegovy: FDA approves higher semaglutide dose as part of new pilot program

Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals. 

READ MORE >
overweight patient seeking health advice
Share on Twitter Share on Facebook Share on Linkedin

Another win for Wegovy: FDA approves higher semaglutide dose as part of new pilot program

Share on Twitter Share on Facebook Share on Linkedin
overweight patient seeking health advice
Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals. 
READ MORE >

Morning exercise may have added benefits for the heart

With exercise, does timing really matter? According to one new study, working out early in the day was linked to a lower risk of heart disease and healthier blood pressure levels than working out at any other point in the day.

READ MORE >
heart patient stretching at home
Share on Twitter Share on Facebook Share on Linkedin

Morning exercise may have added benefits for the heart

Share on Twitter Share on Facebook Share on Linkedin
heart patient stretching at home
With exercise, does timing really matter? According to one new study, working out early in the day was linked to a lower risk of heart disease and healthier blood pressure levels than working out at any other point in the day.
READ MORE >

Ultra-processed foods significantly increase a person’s risk of heart attack or stroke

Study participants who ate high amounts of ultra-processed foods were 66.8% more likely to experience a heart attack, stroke or cardiac arrest than those who did not.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Ultra-processed foods significantly increase a person’s risk of heart attack or stroke

Share on Twitter Share on Facebook Share on Linkedin
Study participants who ate high amounts of ultra-processed foods were 66.8% more likely to experience a heart attack, stroke or cardiac arrest than those who did not.
READ MORE >

FDA announces recall of insulin delivery pods

Small tears were found on the inside of some of Insulet Corporation's Omnipod 5 pods. The issue was linked to a total of 18 serious adverse events.

READ MORE >
Insulet Corporation has announced a voluntary recall for specific lots of the pods associated with its Omnipod 5 Automated Insulin Delivery System
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of insulin delivery pods

Share on Twitter Share on Facebook Share on Linkedin
Insulet Corporation has announced a voluntary recall for specific lots of the pods associated with its Omnipod 5 Automated Insulin Delivery System
Small tears were found on the inside of some of Insulet Corporation's Omnipod 5 pods. The issue was linked to a total of 18 serious adverse events.
READ MORE >

Cold weather responsible for many more stroke and heart attack deaths than heat

While heat consistently gets more attention in terms of public health messaging, new data show just how dangerous the cold can be.

READ MORE >
heart ice cool cold freezing frozen
Share on Twitter Share on Facebook Share on Linkedin

Cold weather responsible for many more stroke and heart attack deaths than heat

Share on Twitter Share on Facebook Share on Linkedin
heart ice cool cold freezing frozen
While heat consistently gets more attention in terms of public health messaging, new data show just how dangerous the cold can be.
READ MORE >

New obesity statistics highlight importance of preventive cardiology

Cardiovascular health is much worse in some parts of the United States than others. Cardiologists in those high-risk areas can make a world of difference by embracing preventive cardiology and working to treat patients before it is too late.

READ MORE >
doctor with overweight patient who may be treated with TAVR or surgery
Share on Twitter Share on Facebook Share on Linkedin

New obesity statistics highlight importance of preventive cardiology

Share on Twitter Share on Facebook Share on Linkedin
doctor with overweight patient who may be treated with TAVR or surgery
Cardiovascular health is much worse in some parts of the United States than others. Cardiologists in those high-risk areas can make a world of difference by embracing preventive cardiology and working to treat patients before it is too late.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant
Is coffee bad for the heart? | FDA approves new hypertension drug | Stolen devices sold to patients | BP drug recalled
OIG questions vascular procedures | Things to consider before signing your next contract | Is coffee bad for the heart?
Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup